Logo Medical Science Monitor

Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST

Contact Us

Logo Medical Science Monitor Logo Medical Science Monitor Logo Medical Science Monitor

02 February 2014: Lab/In Vitro Research  

Relationship between the resistance genes to quaternary ammonium compounds and antibiotic resistance in staphylococci isolated from surgical site infections

Muhyittin Temiz ABCD , Nizami Duran ABCDEFG , Gülay Gülbol Duran ABCE , Naciye Eryılmaz BCD , Kemal Jenedi BC

DOI: 10.12659/MSM.890177

Med Sci Monit 2014; 20:544-550

0 Comments

Abstract

BACKGROUND: We aimed to investigate the prevalence of disinfectant resistance genes (qacA/qacB,qacC) and the aminoglycosides resistance genes [(aac(6’)aph(2’’),aph(3’)-IIIa,ant(4’)-Ia)] in both S. aureus and coagulase-negative staphylococcal strains (CoNS) isolated from surgical site infections.

MATERIAL AND METHODS: Totally, 130 staphylococcal strains isolated from surgical site infections between January 2012 and February 2013 were included in the study. The PCR technique was employed to verify any presence of methicillin resistance gene (mecA), aminoglycoside resistance genes [(aac(6’)/aph (2’’), aph(3)-III a ant (4’)-1a)], and disinfectant resistance genes (qacA/qacB,qacC) in staphylococci.

RESULTS: MecA gene was determined in 58 (44.6%) of 130 staphylococcal isolates. A total of 28 (73.7%) of 38 S. aureus isolates were found to be positive for the mecA gene, and 4 (12.9%) of 31 isolates sensitive to amikacin were sensitive to methicillin. Eighteen (47.4%) of 38 amikacin-resistant S. aureus isolates were found to be positive for qacA/qacB genes and 11 (8.9%) of them were positive for qacC gene. Both mecA and qacA/qacB genes were found to be positive at the same time in 19 amikacin-resistant S. aureus strains. Seven (18.4%) S. aureus isolates were determined to be positive for qacA/qacB and qacC genes. Frequency of qacA/B genes was found to be 47.4% among amikacin-resistant S. aureus strains, while qacC gene was found to be 28.9% (p<0.05). The ratio of qacA/B and qacC genes in CoNS was found to be 37.9% and 20.7%, respectively (p<0.05).

CONCLUSIONS: Quaternary ammonium resistance genes were found to be positive at a remarkable ratio in the staphylococcal isolates from surgical wounds. Especially, the high rates of aminoglycosides and methicillin-resistance gene was remarkable in S. aureus isolates. Quaternary ammonium resistance genes were found to be positive.

Keywords: Chlorhexidine - therapeutic use, Staphylococcal Infections, Drug Resistance, Microbial - drug effects, Amikacin - therapeutic use, Drug Resistance, Microbial - genetics, Genes, Bacterial - genetics, Microbial Sensitivity Tests, Quaternary Ammonium Compounds - therapeutic use, Staphylococcus - isolation & purification, Surgical Wound Infection - microbiology

Background

Mostly caused by staphylococci, surgical site infections are the most common complications occurring after surgery. Staphylococci can cause infections ranging from skin and soft-tissue infections to deep tissue infections such as osteomyelitis, bacteriemia, and endocarditis. Recently, methicillin and antibiotics resistance for various antibiotics have seemed to develop in both nosocomial S. aureus and coagulase-negative staphylococcal strains [1,2].

Very high resistance rates have been reported to develop against widely used antimicrobial agents and disinfectants in both S. aureus and coagulase-negative staphylococci. Combined antibiotics may often be required for the treatment of these kinds of infections caused by resistant bacterial strains. Due to their synergistic effects with many antibiotics, aminoglycosides are often administered in combination with other antibacterial agents in the treatment of staphylococcal infections [2].

As in all other antibiotic groups, resistance to antibiotics is a serious problem for aminoglycosides. The main mechanism of aminoglycoside resistance in staphylococci is based on the drug inactivation by aminoglycoside-modifying enzymes (AMEs). The most common AMEs among staphylococci is 6′-N-acetyltransferase-2″-O-phosphotransferase [aac(6′)-aph(2″)]. It is encoded by aac(6′)-aph-ie (2″) gene. This enzyme fulfills the inactivation of gentamicin, kanamycin, tobramycin, neomycin, and amikacin. Additionally, 4′-Oadenyltransferase I [ant(4′)-I] is encoded by ant(4′)-Ia gene, and it inactivates kanamycin, neomycin, tobramycin, and amikacin. Another enzyme is 3′-O-phosphotransferase III[aph(3′)-III],which inactivates kanamycin and amikacin and is encoded by aph (3′)-IIIa gene [3–7].

To control nosocomial infections, it is essential to secure hygienic conditions in hospitals. Of vital importance is the efficacy of disinfectants used for hand washing and surface disinfectants extensively used in hospitals against microorganisms. Nowadays, the most commonly used disinfectant agents in hospitals are quaternary ammonium compounds [8]. Recently, qac genes (qacA/qacB and qacC or smr), which are the resistance genes to quaternary ammonium compounds, have appeared more frequently in Staphylococcal isolates [9,10].

In this study, we aimed to investigate the prevalence of disinfectant resistance genes (qacA/qacB, qacC) and the aminoglycosides resistance genes [(aac(6′)aph(2″),aph(3′)-IIIa,ant(4′)-Ia)] in S. aureus and coagulase-negative staphylococcal strains isolated from surgical site infections. We also tried to determine, the relationship, if any, between the disinfectant resistance genes and the aminoglycosides resistance genes.

Material and Method

BACTERIAL ISOLATES:

The study involved a total of 130 consecutive isolates of staphylococci collected from Mustafa Kemal University Research Hospital, Department of General surgery. Bacterial isolates were obtained postoperatively from various infected wounds. To isolate staphylococci, samples were inoculated onto sheep blood agar plates and phenol-red mannitol salt agar plates. The plates were incubated at 37°C for 48 h. Identification of staphylococci was based upon colony morphology, biochemical activities, and coagulase test results [11]. If necessary, further confirmatory tests were done with the Vitek-2 automated microbiology system (bioMerieux, France).

DISC DIFFUSION METHOD: Antimicrobial susceptibilities of the isolates to amikacin were tested by the agar disk diffusion method on Mueller-Hinton agar (Tiantan Biotechnology, PR China) according to the Clinical and Laboratory Standards Institute (CLSI) guidelines [12]. All antibiotic discs [oxacillin (1 μg) and amikacin (10 μg)], were obtained from Oxoid. Mueller-Hinton broth was used as the growth medium. Plates were incubated aerobically at 35°C and 37°C for 24 h in oxacillin and amikacin susceptibilities tests, respectively. The diameter of each zone was measured in millimeters.

QUALITY CONTROL ORGANISMS:

S. aureus ATCC 29213 and S. aureus ATCC (43300) were chosen as the negative and positive control strains, respectively.

BROTH MICRODILUTION SUSCEPTIBILITY TESTS: The minimum inhibitory concentrations (MICs) of chlorhexidine were determined by the reference broth microdilution procedure recommended by the CLSI. At the end of incubation, the MIC was defined as the lowest concentration of antibiotics that produced no growth [13].

:

Primers specific for mecA, femA, aac(6′)/aph(2″), aph(3′)-IIIa, and ant(4′)-Ia were selected from the studies of Strommenger et al. [14], Martineau et al. [15], and Duran et al. [16] (Table 1). The oligonucleotide primers for the qacA/qacB and qacC genes were selected based on the study by Zmantar et al. (Table 1) [17].

Multiplex PCR assay was carried out for the detection of mecA, femA, aac(6′)/aph(2″), aph(3′)-IIIa, ant(4′)-Ia, qacA/qacB, and qacC genes in all staphylococcal strains. PCR amplification was carried out in a total volume of 25 μl. PCR amplification was achieved as follows: 5 μl of genomic DNA (approximately 50 ng) sample was added to 20 μl of PCR mixture (20 mmol/L Tris-HCl, pH 8.4; 50 mmol/L KCl, 10 mmol/L MgCl2) and 200 μmol/L each of deoxynucleoside triphosphates (dNTPs), 0.6 μmol/L each primers and 1 U Taq DNA polymerase. The amplification process for mecA, femA, aac(6′)/aph(2″), aph(3′)-IIIa and ant(4′)-Ia was started with an initial denaturation step (94°C, 4 min). Each cycle consists of 3 steps: denaturation, annealing, and extension. Each PCR reaction consisted of 30 cycles of amplification. Amplification consisted of denaturation at 94°C for 45 s, annealing at 52°C for 30 s, and DNA chain extension at 72°C for 1 min.

The amplification process for qacA/qacB and qacC was started with an initial denaturation step (94°C, 5 min). Each cycle consists of 3 steps: denaturation, annealing, and extension. Each PCR reaction consisted of 30 cycles of amplification. Amplification consisted of denaturation at 94°C for 1.5 min, annealing at 56°C for 30 s, and DNA chain extension at 72°C for 1.5 min. A final extension cycle was performed at 72°C for 7 min.

After the amplification of the slime and adhesin genes, 10 μL volumes of PCR samples were mixed with 3 μL of loading buffer (10%, w/v, Ficoll 400; 10 mmol/L Tris-HCl, pH 7.5; 50 mmol/L EDTA; 0.25% bromophenol blue). The PCR products were analyzed in a 2% (w/v) agarose gel in 1xTAE buffer (40 mmol/L Tris-acetate, 1 mmol/L EDTA). Ethidium bromide (0.5 μg/mL TAE)-stained DNA amplicons were visualized using a gel imaging system (Wealtec, Dolphin-View, USA).

STATISTICAL ANALYSIS:

Statistical analysis was performed using the chi-square test and p values less than 0.05 were considered statistically significant. The statistical analyses were performed using Statistical Package for Social Sciences (SPSS, ver. 17.5, Chicago, USA) software.

Results

We found that 69 of the isolates (53.1%) were coagulase positive. MecA gene was determined in 58 (44.6%) of 130 staphylococcal isolates. A total of 28 (73.7%) of 38 S. aureus isolates were positive for the mecA gene, and 4 (12.9%) of 31 isolates sensitive to amikacin were sensitive to methicillin. Eighteen (47.4%) of 38 amikacin-resistant S. aureus isolates were positive for qacA/qacB genes and 11 (%8.9%) were positive for qacC gene. mecA and qacA/qacB genes were positive at the same time in 19 amikacin-resistant S. aureus strains, and 7 (18.4%) S. aureus isolates were positive for qacA/qacB and qacC genes (Table 2).

In addition, 20 (69.0%) of 29 amikacin-resistant coagulase-negative staphylococci were found to carry mecA gene, while 6 (18.8) of 32 amikacin-sensitive isolates carried the methicillin resistance gene. Eleven (37.9%) and 6 (20.7%) of 29 amikacin-resistant coagulase-negative staphylococci were positive for qacA/qacB genes and qacC genes, respectively. In addition, 4 (13.8%) and 2 (6.9%) of these strains were positive for mecA and qacA/qacB genes, and mecA and qacC genes, respectively (Table 2). Aminoglycoside resistance genes were detected by PCR method in all of the 38 S. aureus strains, which were phenotypically determined to have amikacin resistance, while 3 (9.7%) of the 31 S. aureus strains sensitive to amikacin were found to carry aac(6′)/aph(2″) genes. The aph (3′)-IIIa gene was identified in 1 strain (3.2%). Similarly, all 29 amikacin-resistant coagulase-negative strains had at least 1 aminoglycoside-resistant gene, while aac(6′)/aph(2″, aph(3′)-IIIa, and ant(4′)-Ia genes were 6.3%, (2/32), 9.4% (3/32) and 3.1% (1/32) positive, respectively, in the 32 strains found to be phenotypically susceptible to amikacin (Table 2).

The occurrence of mecA gene among amikacin-resistant S. aureus strains was determined as 73.7%, and this ratio was 12.9% among amikacin-sensitive S. aureus strains. There was a statistically significant difference among the methicillin-sensitive and -resistant strains in amikacin resistance (p<0.001). This difference was also recognized among coagulase-negative strains. Occurrence of methicillin resistance genes among amikacin-resistant S. aureus strains was 69.0%, and the same ratio was 18.8% among coagulase-negative strains (Table 2).

Frequency of qacA/B genes was 47.4% among amikacin-resistant S. aureus strains, while qacC gene was 28.9% (p<0.05). The ratio of qacA/B and qacC genes in CoNS was 37.9% and 20.7%, respectively (p<0.05).

At least 1 of the amikacin resistance genes existed in 38 amikacin-resistant S. aureus strains. The aac(6′)/aph(2″) resistance gene positivity (48.6%) was highest, followed by aph(3′)-IIIa (28.9%) and ant (4′)-Ia (26.3%) genes. As in S. aureus isolates, at least 1 or more resistance genes existed in all of the amikacin-resistant CoNS. Two amikacin-sensitive CoNS had aac(6′)aph(2″) gene, while 3 CoNS had aph(3)-IIIa gene (Table 3). It was observed that 2 amikacin-sensitive CoNS had aac(6′)aph(2″) gene, while 3 CoNS had aph(3)-IIIa gene (Table 3).

We found that mecA gene and qacA/B genes were both positive in 27 (20.8%) staphylococcal isolates, while mecA and qacC occurred in 10 (7.7%) of the isolates. Methicillin and qacA/B genes positivity were determined in 50% of 38 amikacin-resistant S. aureus isolates, while qacC gene was detected in 18.4% of them. Of a total of 38 S. aureus isolates, 68.4% carried both methicillin and disinfectant resistance genes. Similarly, qacA/B genes were positive in 14.8% of 29 amikacin-resistant CoNS, while qacC gene was observed in 2 (6.9%) isolates. There was a significant difference between S. aureus isolates carrying mecA genes and CoNS carrying mecA genes containing the disinfectant resistance genes. Methicillin and disinfectant resistance genes were detected in 20.7% of amikacin-resistant CoNS. mecA plus qacA positivity was detected as 9.7% of the 31 S. aureus strains that were resistant to amikacin. No common positivity for mecA and qacA was found (p<0.01) among the amikacin-sensitive S. aureus strains. One isolate was positive for mecA and qacA/B genes among amikacin-sensitive CoNS, and 1 isolate was positive for mecA plus qacC genes (Table 4).

Chlorhexidine MIC values were determined as 0.5–8 mg/l. Chlorhexidine resistance was 50.7% among S. aureus isolates carrying qacA/B genes, while the same ratio was 29.5% among CoNS isolates (p<0.01). Chlorhexidine resistance was detected in all of the 24 S. aureus strains whose qacA/B genes were positive, while chlorhexidine resistance was positive in 11 of 13 qacC genes (84.6%) (p<0.05). Chlorhexidine resistance was determined in 13 (92.3%) of 14 isolates among CoNS strains that were detected with qacA/B gene, while chlorhexidine resistance was observed in 5 of 6 CoNS strains (83.3%) with qacC gene positivity (Table 5).

Discussion

A number of disinfectant agents are used for both hand hygiene and the prevention of nosocomial infections. It has been reported that qacA/B and qacC (or smr) genes transmitted by plasmids are responsible for the development of resistance in staphylococci against cationic antiseptic agents. Medically, S. aureus and CoNS are remarkable microorganisms, which may cause diseases of skin and soft-tissue, as well as bacteremia and endocarditis. Staphylococci can readily develop resistance to most antimicrobial agents, including antiseptic and disinfectants [18,19].

Quaternary ammonium compounds are disinfectants frequently used for controlling nosocomial infections. Recently, resistance to quaternary ammonium compounds has frequently appeared among clinical staphylococcal strains. In a study exploring the relation between the antiseptic resistance genes (qacA/B, qacC) and antibiotic resistance in clinical S. aureus isolates, it was observed that qacC genes occurred at a higher ratio than did qacA/B genes. Presence of qacC gene was positive in 36% of MRSA isolates. No qacC resistance gene could be detected in MSSA isolates, but qacA/B gene was positive in them at the rate of 4%. In that study, smr resistance gene was detected only in MRSA isolates, while qacA/B genes were determined in MRSA isolates at lower rates [20]. Unlike this study, qacA/B ratio in MRSA isolates was found to be statistically significantly higher than qacC ratio (p<0.01) in our study. In contrast, in our research qacC resistance gene was detected both in MRSA and methicillin-sensitive CoNS isolates. In addition, qacA/B and qacC resistance genes were found positive in 8.2% (5/61) and 4.9% (3/61) CoNS, respectively.

Previous studies have reported that the frequency of occurrence of disinfectant resistance genes varied from country to country and even from hospital to hospital. Noguchi et al. studied the frequency of disinfectant genes in MRSA strains. For this purpose, they used clinical MRSA isolates from different countries. QacC gene frequency among MRSA isolates from Indian isolates was 31.6%, while the same values were 1.9% in Asian samples. QacA/B frequency in Asian isolates was reported to be 41.6% and these isolates were found resistant to acriflavine at the rate of 57.7%. In the study, it was pointed out that qacA/B genes were widespread in MRSA isolates in Asia and that qacA/B play role in resistance to disinfectants [21]. In our study, the frequency of qacA/B genes with Asian roots was rather high. Chlorhexidine resistance was found in 28.5% of the isolates carrying qacA/B genes.

In a study by Zhanq et al., [22], the relation between efflux proteins was encoded by qac genes and biocide resistance. They investigated the prevalence of antiseptic resistance genes (qacA/qacB qacC) in staphylococci colonized in medical staff and nurses and found that qacA/B and qacC genes were related to the presence of mecA genes. In addition, rather high antibiotic resistance was detected in S. aureus strains where presence of qac genes was verified and in all qac gene-positive isolates, and quite high MIC and MBC values were found against antiseptics [22].

In our study, qacA/B ratio was 20.8% in 27 isolates in which presence of mecA gene was verified, while qacC genes existed at the rate of 7.7%. We also found a high chlorhexidine resistance value in isolates in which qacA/qaB and qacC resistance genes were verified. Our findings are in line with the results of Zhang and et al. [22].

In a study conducted in Malaysia in 2012 to investigate the frequency of antiseptic resistance genes in MRSA strains, it was determined that antiseptic resistance genes qacA/B and qacC occurred in 83.3% and 1.6% of the isolates, respectively. It was established in the study that qacA/B genes carriage leads to decline in chlorhexidine digluconate and benzethonium sensitivity. It was reported that MIC values were 0.5 to 2 mg/l against 3 disinfectant agents (benzalkonium chloride, benzethonium chloride, and chlorhexidine digluconate) in MRSA strains. The presence of antiseptic resistance genes was reported to be related to rising resistance values against disinfectant agents [23]. In our study, chlorhexidine MIC value was determined as 0.5–8 mg/l in isolates in which qacA/B and qacC genes were detected, and MIC value was <1 mg/l in strains where no resistance genes were detected.

Chlorhexidine is among the most widely used disinfectants for controlling nosocomial infections. Although chlorhexidine-impregnated catheter practice is reported to reduce catheter-related infections, chlorhexidine resistant S. aureus isolates have been found in recent years. In a study investigating MRSA isolates, the efficiency of chlorhexidine resistance genes (qacA and qacA/B), and chlorhexidine-impregnated catheters, MIC values against chlorhexidine in qacA/B genes carrying S. aureus isolates were >2 mg/l, while the MIC values in isolates not carrying qacA/B genes were >1 mg/l. It was also found out that MIC values were 1 mg/l in MSSA isolates and 2 mg/l in MRSA isolates, and qacA/B prevalence in MRSA and MSSA isolates was 43.8% and 3.3%, respectively. The prevalence of qacC gene in MRSA and MSSA isolates was 5% and 25%, respectively [24]. As in this study, MIC values against chlorhexidine were found to be high (>2–8) in our study.

In a study of 522 S. aureus isolates from a hospital in Japan, qacA and qacB genes were investigated; the presence of qacA/B in MRSA isolates was 32.6% and that of qacA/B genes was 7.5% among MSSA isolates. The presence of qacC in MRSA and MSSA isolates was 3.3% and 5.9%, respectively. Among S. aureus isolates, qacA/B gene frequency was widespread. In qacA/B-positive isolates, qacB and qacA genes were positive at the rate of 59.3% and 40.7%, respectively [25]. As in our study, qacA/B genes were more frequent among MRSA isolates.

In a study carried out with 98 methicillin-resistant clinical isolates, distribution and sensitiveness to antiseptics of antiseptic resistance genes (qacA and qacC) were investigated. Frequencies of qacA and qacC were 20.2% and 20.4%, respectively [26].

In our study, qacC gene prevalence was at a lower level than in the study by Nogachi et al. [26]. The disinfectant resistance genes (qacA/B, qacC) frequency was determined as a remarkably high ratio in this first study conducted in our region. In our hospital, the prevalence of qacA/B genes was higher than that of qacC gene. There was a statistically significant difference between the qacA/B gene-positive and qacA/B gene-negative groups in chlorhexidine resistance. Similarly, resistance to chlorhexidine was significantly higher in presence of qacC gene.

In our study, 68.7% of the isolates in which antiseptic resistance genes were detected had amikacin resistance, while in the isolates lacking disinfectant resistance genes, amikacin resistance was 31.3%.

Conclusions

Rather high resistance to chlorhexidine was determined in the isolates found to carry qacA/B and qacC antiseptic resistance genes. Our findings indicate a significant relation between the presence of qacA/B and qacC resistance genes and amikacin and methicillin resistance.

Quaternary ammonium resistance genes were found to be positive at a remarkable ratio in the staphylococcal isolates from the surgical wounds. The rates of aminoglycoside- and methicillin-resistance genes were remarkably high in S. aureus isolates, especially when quaternary ammonium resistance genes were positive.

References

1. Yavuz SS, Tarcin O, Ada S, Incidence, aetiology, and control of sternal surgical site infections: J Hosp Infect, 2013; 85(3); 206-12, pmid: 24035582

2. Lowy FD: N Engl J Med, 1998; 339(8); 520-32, pmid: 9709046

3. Ozyurt M, Sareyyüpoglu B, Ardic N, Investigation of methicillin resistance and aminoglycoside modifying enzyme genes in hospital staphylococci by multiplex-polymerase chain reaction: Mikrobiyol Bul, 2005; 39(1); 1-8, pmid: 15900831

4. Choi SM, Kim SH, Kim HJ: J Korean Med Sci, 2003; 18; 631-36, pmid: 14555812

5. Yadegar A, Sattari M, Mozafari NA: Microb Drug Resist, 2009; 15; 109-13, pmid: 19496674

6. Kim HB, Kim T, Lee BB: Korean J Infect Dis, 2002; 34; 39-46

7. Sekiguchi J, Fujino T, Saruta K: Jpn J Infect Dis, 2004; 57; 74-77, pmid: 15118216

8. Smith K, Gemmell CG, Hunter IS, The association between biocide tolerance and the presence or absence of qac genes among hospital-acquired and community-acquired MRSA isolates: J Antimicrob Chemother, 2008; 61(1); 78-84, pmid: 17981834

9. Vali L, Davies SE, Lai LL: J Antimicrob Chemother, 2008; 61(3); 524-32, pmid: 18227090

10. Heir E, Sundheim G, Holck AL, Identification and characterization of quaternary ammonium compound resistant staphylococci from the food industry: Int J Food Microbiol, 1999; 48(3); 211-19, pmid: 10443540

11. Kloos WE, Schleifer KH, Staphylococcus: BergeyOs manual of systematic bacteriology, 1986; 2; 1013-19, Baltimore, MD, The Williams and Wilkins Co.

12. Clinical and Laboratory Standards Institute, Performance standards for antimicrobial susceptibility testing: CLSI approved standard M100-S23, 2013, Wayne, PA, Clinical and Laboratory Standards Institute

13. Clinical and Laboratory Standards Institute, Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically: Approved standard M7-A7, 2006, Wayne, Pa, Clinical and Laboratory Standards Institute

14. Strommenger B, Kettlitz C, Werner G: J Clin Microbiol, 2003; 41; 4089-94, pmid: 12958230

15. Martineau F, Picard FJ, Lansac N: Antimicrob Agents Chemother, 2000; 44; 231-38, pmid: 10639342

16. Duran N, Ozer B, Duran GG, Antibiotic resistance genes & susceptibility patterns in staphylococci: Indian J Med Res, 2012; 135; 389-96, pmid: 22561627

17. Zmantar T, Kouidhi B, Miladi H: BMC Res Notes, 2011; 4; 453-64, pmid: 22032892

18. Duran N, Dogramaci Y, Demir C: Med Sci Monit, 2010; 16(8); BR271-77, pmid: 20671608

19. Ozer B, Ozbakıs Akkurt BC, Duran N, Turhanoglu S, Evaluation of nosocomial infections and risk factors in critically ill patients: Med Sci Monit, 2011; 17(3); PH17-22, pmid: 21358613

20. Nakipoğlu Y, Ignak S, Gürler NThe prevalence of antiseptic resistance genes (qacA/B and smr) and antibiotic resistance in clinical strains: Mikrobiyol Bul, 2012; 46(2); 180-89, pmid: 22639307

21. Noguchi N, Suwa J, Narui K: J Med Microbiol, 2005; 54(Pt 6); 557-65, pmid: 15888465

22. Zhang M, O’Donoghue MM, Ito T: J Hosp Infect, 2011; 78(2); 113-17, pmid: 21507521

23. Shamsudin MN, Alreshidi MA, Hamat RA: J Hosp Infect, 2012; 81(3); 206-8, pmid: 22633074

24. Ho CM, Li CY, Ho MW: Antimicrob Agents Chemother, 2012; 56(11); 5693-97, pmid: 22908163

25. Alam MM, Kobayashi N, Uehara N: Microb Drug Resist, 2003; 9(2); 109-21, pmid: 12820795

26. Noguchi N, Hase M, Kitta M: FEMS Microbiol Lett, 1999; 172(2); 247-53, pmid: 10188253

In Press

Clinical Research  

Institutional and Regional Variations in Access to Clinical Trials and Next-Generation Sequencing in Turkis...

Med Sci Monit In Press; DOI: 10.12659/MSM.951027  

Clinical Research  

Low-Intensity Blood Flow-Restricted Multi-Joint Exercise Improves Muscle Function in Patients With Patellof...

Med Sci Monit In Press; DOI: 10.12659/MSM.950516  

Review article  

Musculoskeletal Ultrasound and MRI in the Evaluation of Chemotherapy-Induced Peripheral Neuropathy: A Review

Med Sci Monit In Press; DOI: 10.12659/MSM.951283  

Clinical Research  

Sensory Processing, Dissociation, and Affective Symptoms in Misophonia: A Cross-Sectional Study of 35 Adults

Med Sci Monit In Press; DOI: 10.12659/MSM.950938  

Most Viewed Current Articles

17 Jan 2024 : Review article   10,187,196

Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron Variant

DOI :10.12659/MSM.942799

Med Sci Monit 2024; 30:e942799

0:00

13 Nov 2021 : Clinical Research   3,708,487

Acceptance of COVID-19 Vaccination and Its Associated Factors Among Cancer Patients Attending the Oncology ...

DOI :10.12659/MSM.932788

Med Sci Monit 2021; 27:e932788

0:00

14 Dec 2022 : Clinical Research   2,341,643

Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase Levels

DOI :10.12659/MSM.937990

Med Sci Monit 2022; 28:e937990

0:00

16 May 2023 : Clinical Research   706,524

Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...

DOI :10.12659/MSM.940387

Med Sci Monit 2023; 29:e940387

0:00

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Medical Science Monitor eISSN: 1643-3750
Medical Science Monitor eISSN: 1643-3750